TY  - GEN
AU  - Rowe,Jacob M
TI  - Evaluation of prognostic factors in AML. Preface
SN  - 1532-1924
PY  - 2012///0409
KW  - Aged
KW  - Aminoglycosides
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - CCAAT-Enhancer-Binding Proteins
KW  - genetics
KW  - Cytarabine
KW  - DNA (Cytosine-5-)-Methyltransferases
KW  - DNA Methyltransferase 3A
KW  - Europe
KW  - epidemiology
KW  - Gemtuzumab
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Middle Aged
KW  - Mutation
KW  - Prognosis
KW  - Survival Analysis
KW  - United States
N1  - Publication Type: Congress; Editorial
UR  - https://doi.org/10.1016/j.beha.2011.09.003
ER  -